TIM-3 expression and markers of immune escape on leukemia

被引：0
|
作者：
Kuzelova, K. [1 ]
Brodska, B. [1 ]
Otevrelova, P. [1 ]
Salek, C. [2 ]
机构：
[1] Inst Hematol & Blood Transfus, Prote Dept, Prague, Czech Republic
[2] Inst Hematol & Blood Transfus, Clin Dept, Prague, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
188P
引用
收藏
页码：S1463 / S1463
页数：1
相关论文
共 50 条
  • [41] TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma
    Valente, Sofia
    Nascimento, Catarina
    Gameiro, Andreia
    Ferreira, Joao
    Correia, Jorge
    Ferreira, Fernando
    CANCERS, 2023, 15 (02)
  • [42] Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity
    Zhang, Zhaoying
    Ren, Caiyue
    Xiao, Rong
    Ma, Shuaiya
    Liu, Huimin
    Dou, Yutong
    Fan, Yuchen
    Wang, Shuo
    Zhan, Peng
    Gao, Chengjiang
    Yue, Xuetian
    Li, Chunyang
    Gao, Lifen
    Liang, Xiaohong
    Wu, Zhuanchang
    Ma, Chunhong
    SCIENCE IMMUNOLOGY, 2024, 9 (101)
  • [43] TIM-3 Regulates Innate Immune Cells To Induce Fetomaternal Tolerance
    Chabtini, Lola
    Mfarrej, Bechara
    Mounayar, Marwan
    Zhu, Bing
    Batal, Ibrahim
    Dakle, Pranal J.
    Smith, Brian D.
    Boenisch, Olaf
    Najafian, Nader
    Akiba, Hisaya
    Yagita, Hideo
    Guleria, Indira
    JOURNAL OF IMMUNOLOGY, 2013, 190 (01): : 88 - 96
  • [44] REGULATION OF TIM-3 BY PHOSPHATIDYLSERINE
    Smith, Courtney
    Li, Alice
    Krishnamurthy, Nithya
    Lemmon, Mark
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A126 - A126
  • [45] Time to target TIM-3 in colorectal cancer: TIM-3 expression to predict survival outcomes in patients in CALGB (Alliance)/SWOG 80405
    Algaze, Sandra
    Yang, Yan
    Millstein, Joshua
    Battaglin, Francesca
    Soni, Shivani
    Mittal, Pooja
    Ashouri, Karam
    Jayachandran, Priya
    Arai, Hiroyuki
    Lo, Jae Ho
    Zhang, Wu
    Torres-Gonzalez, Lesly
    Wong, Alexandra
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
    Anderson, Ana C.
    Anderson, David E.
    Bregoli, Lisa
    Hastings, William D.
    Kassam, Nasim
    Lei, Charles
    Chandwaskar, Rucha
    Karman, Jozsef
    Su, Ee W.
    Hirashima, Mitsuomi
    Bruce, Jeffrey N.
    Kane, Lawrence P.
    Kuchroo, Vijay K.
    Hafler, David A.
    SCIENCE, 2007, 318 (5853) : 1141 - 1143
  • [47] TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
    Fucikova, Jitka
    Rakova, Jana
    Hensler, Michal
    Kasikova, Lenka
    Belicova, Lucie
    Hladikova, Kamila
    Truxova, Iva
    Skapa, Petr
    Laco, Jan
    Pecen, Ladislav
    Praznovec, Ivan
    Halaska, Michael J.
    Brtnicky, Tomas
    Kodet, Roman
    Fialova, Anna
    Pineau, Josephine
    Gey, Alain
    Tartour, Eric
    Ryska, Ales
    Galluzzi, Lorenzo
    Spisek, Radek
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4820 - 4831
  • [48] The rise of TIM-3: A promising immune target in diffuse midline gliomas
    Ausejo-Mauleon, Iker
    Nuin, Sara
    Alonso, Marta M.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (01):
  • [49] Tim-3: an activation marker and activation limiter of innate immune cells
    Han, Gencheng
    Chen, Guojiang
    Shen, Beifen
    Li, Yan
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [50] Galectin-9 drives TIM-3 mediated immune suppression
    Deshpande, Amit M.
    Fontana, Rachel
    Zhang, Yue
    Ruisi, Mary
    Zhang, Dong
    Senger, Tilo
    Rolfe, P. Alexander
    CANCER RESEARCH, 2018, 78 (13)
12345